Minerva Advisors LLC Boosts Position in Utah Medical Products, Inc. (NASDAQ:UTMD)

Minerva Advisors LLC raised its position in Utah Medical Products, Inc. (NASDAQ:UTMD - Free Report) by 85.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 78,389 shares of the medical instruments supplier's stock after acquiring an additional 36,061 shares during the quarter. Utah Medical Products makes up 2.8% of Minerva Advisors LLC's investment portfolio, making the stock its 12th largest position. Minerva Advisors LLC owned 2.31% of Utah Medical Products worth $4,819,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of UTMD. Golden State Wealth Management LLC purchased a new position in Utah Medical Products during the 4th quarter valued at $31,000. R Squared Ltd bought a new position in shares of Utah Medical Products in the 4th quarter worth about $49,000. BNP Paribas Financial Markets lifted its holdings in shares of Utah Medical Products by 102.7% during the third quarter. BNP Paribas Financial Markets now owns 1,117 shares of the medical instruments supplier's stock valued at $75,000 after purchasing an additional 566 shares during the last quarter. SG Americas Securities LLC bought a new stake in Utah Medical Products in the fourth quarter worth $157,000. Finally, Virtu Financial LLC bought a new position in shares of Utah Medical Products during the third quarter valued at $207,000. 69.60% of the stock is owned by institutional investors.

Utah Medical Products Stock Performance

Shares of NASDAQ:UTMD traded down $0.14 during trading on Friday, reaching $59.61. 22,192 shares of the stock traded hands, compared to its average volume of 22,649. The stock has a market cap of $202.20 million, a P/E ratio of 15.09 and a beta of 0.08. The stock has a 50-day moving average of $61.23 and a two-hundred day moving average of $64.25. Utah Medical Products, Inc. has a 52-week low of $58.87 and a 52-week high of $77.33.

Utah Medical Products (NASDAQ:UTMD - Get Free Report) last released its quarterly earnings data on Tuesday, January 28th. The medical instruments supplier reported $0.86 earnings per share (EPS) for the quarter. Utah Medical Products had a return on equity of 11.07% and a net margin of 33.92%.

Utah Medical Products Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, April 3rd. Investors of record on Friday, March 14th will be given a dividend of $0.305 per share. The ex-dividend date of this dividend is Friday, March 14th. This represents a $1.22 annualized dividend and a dividend yield of 2.05%. Utah Medical Products's dividend payout ratio (DPR) is presently 30.89%.

Wall Street Analyst Weigh In

Separately, StockNews.com cut shares of Utah Medical Products from a "strong-buy" rating to a "buy" rating in a research note on Thursday, November 7th.

Utah Medical Products Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.